Compare Humana Inc (HUM) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Marsh & McLennan Companies, Inc. trades at $176.51 (market cap $82.87B). The key difference: Marsh & McLennan Companies, Inc. is the larger of the two by market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.28%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.
| HUM | MRSH | |
|---|---|---|
Market Cap | $47.61B | $82.87B |
Volume | 1,827,332 | 2,731,994 |
Sector | Health | Financials |
52-Week High | $409.85 | $207.02 |
52-Week Low | $163.67 | $157.32 |
Typical Hold Time | 53 Days | 109 Days |
Enterprise Value | $54.97B | $103.55B |
Dividend Yield | 0.89% | 2.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Marsh (MRSH) trades at $176.67, up 2.86% today, with a bullish technical signal and strong fundamentals including a 14.24% net income margin and consistent earnings beats. The recent acquisition of Accel Holdings, completed October 2, 2026, enhances its global advisory services. Revenue grew to $26.98B in 2025, and cash flow from operations remains robust at $5.29B, supporting a stable financial position.
The stock offers upside to the consensus price target of $202.71, but risks include high debt levels and competitive pressures. Analyst sentiment is mixed with a 'Hold' consensus, while technical indicators show overbought conditions near resistance at $177. Long-term growth depends on integration of acquisitions and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
